PlexBio Co., Ltd. (6572) Stock Statistics & Valuation Metrics
Total Valuation
PlexBio Co., Ltd. has a market cap or net worth of TWD 630.19M. The enterprise value is ―.
- Market Cap
- TWD 630.19M
- Enterprise Value
- ―
Share Statistics
PlexBio Co., Ltd. has 103,649,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 103,649,510
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
PlexBio Co., Ltd.’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -19.41%.
- Return on Equity (ROE)
- -0.20
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -19.41%
- Return on Capital Employed (ROCE)
- -0.20
- Revenue Per Employee
- 6.35M
- Profits Per Employee
- -3.12M
- Employee Count
- 20
- Asset Turnover
- 0.28
- Inventory Turnover
- 1.73
Valuation Ratios
The current PE Ratio of PlexBio Co., Ltd. is -17.49. PlexBio Co., Ltd.’s PEG ratio is -0.41.
- PE Ratio
- -17.49
- PS Ratio
- 4.87
- PB Ratio
- 2.30
- Price to FCF
- -14.16
- Price to Operating Cash Flow
- -13.96
- PEG Ratio
- -0.41
Income Statement
In the last 12 months, PlexBio Co., Ltd. had revenue of 127.09M and earned -62.47M in profits. Earnings per share was -0.60.
- Revenue
- 127.09M
- Gross Profit
- 40.22M
- Operating Income
- -65.65M
- Pretax Income
- -62.47M
- Net Income
- -62.47M
- EBITDA
- -49.16M
- Earnings Per Share (EPS)
- -0.60
Cash Flow
In the last 12 months, operating cash flow was -47.58M and capital expenditures 226,000, giving a free cash flow of -47.35M billion.
- Operating Cash Flow
- -47.58M
- Free Cash Flow
- -47.35M
- Free Cash Flow per Share
- -0.46
Dividends & Yields
PlexBio Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.06%
- Earnings Yield
- -5.78%
Stock Price Statistics
- Beta
- 0.68
- 52-Week Price Change
- -34.48%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 38.26
- Average Volume (3m)
- 195.30K
Financial Position
PlexBio Co., Ltd. as a current ratio of 3.57, with Debt / Equity ratio of 3.08%
- Current Ratio
- 3.57
- Quick Ratio
- 3.14
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 3.69
- Interest Coverage Ratio
- -247.72
Taxes
In the past 12 months, PlexBio Co., Ltd. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PlexBio Co., Ltd. EV to EBITDA ratio is -13.48, with an EV/FCF ratio of -11.19.
- EV to Sales
- 3.85
- EV to EBITDA
- -13.48
- EV to Free Cash Flow
- -11.19
- EV to Operating Cash Flow
- -11.14
Balance Sheet
PlexBio Co., Ltd. has TWD 283.20M in cash and marketable securities with TWD 5.23M in debt, giving a net cash position of TWD 277.97M billion.
- Cash & Marketable Securities
- TWD 283.20M
- Total Debt
- TWD 5.23M
- Net Cash
- TWD 277.97M
- Net Cash Per Share
- TWD 2.68
- Tangible Book Value Per Share
- TWD 2.81
Margins
Gross margin is 33.87%, with operating margin of -39.77%, and net profit margin of -27.90%.
- Gross Margin
- 33.87%
- Operating Margin
- -39.77%
- Pretax Margin
- -27.90%
- Net Profit Margin
- -27.90%
- EBITDA Margin
- -28.58%
- EBIT Margin
- -39.77%
Analyst Forecast
The average price target for PlexBio Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -10.12%
- EPS Growth Forecast
- 40.52%
